Активность лактоферрина различного происхождения в отношении грамположительных кокков и Candida albicans

Q3 Medicine
В. Н. Зорина, О. Н. Воробьева, Н. А. Зорин
{"title":"Активность лактоферрина различного происхождения в отношении грамположительных кокков и Candida albicans","authors":"В. Н. Зорина, О. Н. Воробьева, Н. А. Зорин","doi":"10.36233/0372-9311-2018-2-54-58","DOIUrl":null,"url":null,"abstract":"Aim. A comparative study of the effect ofbovine and human lactoferrin (LF) on Staphylococcus aureus, Staphylococcus epidermidis, Enterococcus faecalis, Candida albicans strains. Materials and methods. The daily agar cultures of museum and clinical strains of microorganisms were standardized, diluted with physiological solution up (from 5000 microbial cells/ ml to 0.1 ml) was added to the stepwise dilution of LF (from 1000 pg /ml) and incubated 18 - 24 hours at 37°C. The amount of LF in the sample with the total apparent growth retardation of the microbes was the minimum inhibitory concentration (MIC) for the strain. Results. The MIC of human LF was 4 - 8 times less than MIC of bovine LF. The smallest dose was required for the suppression of C. albicans (11.3±1.5 and 43.8±9.5 pg/ml respectively), the largest when using human LF was needed to suppress S. aureus (38,2±4,6), and in a case of bovine LF - E. faecalis (206,3±51,1). Conclusion. Human LF is much more effective in suppressing bacterial infection, but in the course of evolution, there is an increase in the resistance of S. aureus to LF. The higher availability of bovine LF and the lack of a tendency to increase resistance, it is advisable to use high-doses of bovine LF in the treatment of resistant forms of bacteria and C. albicans.","PeriodicalId":24020,"journal":{"name":"Zhurnal mikrobiologii, epidemiologii, i immunobiologii","volume":"42 1","pages":"54-58"},"PeriodicalIF":0.0000,"publicationDate":"2018-04-28","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"2","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Zhurnal mikrobiologii, epidemiologii, i immunobiologii","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.36233/0372-9311-2018-2-54-58","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q3","JCRName":"Medicine","Score":null,"Total":0}
引用次数: 2

Abstract

Aim. A comparative study of the effect ofbovine and human lactoferrin (LF) on Staphylococcus aureus, Staphylococcus epidermidis, Enterococcus faecalis, Candida albicans strains. Materials and methods. The daily agar cultures of museum and clinical strains of microorganisms were standardized, diluted with physiological solution up (from 5000 microbial cells/ ml to 0.1 ml) was added to the stepwise dilution of LF (from 1000 pg /ml) and incubated 18 - 24 hours at 37°C. The amount of LF in the sample with the total apparent growth retardation of the microbes was the minimum inhibitory concentration (MIC) for the strain. Results. The MIC of human LF was 4 - 8 times less than MIC of bovine LF. The smallest dose was required for the suppression of C. albicans (11.3±1.5 and 43.8±9.5 pg/ml respectively), the largest when using human LF was needed to suppress S. aureus (38,2±4,6), and in a case of bovine LF - E. faecalis (206,3±51,1). Conclusion. Human LF is much more effective in suppressing bacterial infection, but in the course of evolution, there is an increase in the resistance of S. aureus to LF. The higher availability of bovine LF and the lack of a tendency to increase resistance, it is advisable to use high-doses of bovine LF in the treatment of resistant forms of bacteria and C. albicans.
不同来源的乳糖ferrin与葡萄糖和白化病有关。
的目标。牛与人乳铁蛋白(LF)对金黄色葡萄球菌、表皮葡萄球菌、粪肠球菌、白色念珠菌影响的比较研究。材料和方法。标准化博物馆和临床微生物菌种的日常琼脂培养物,用生理溶液稀释(从5000个微生物细胞/ml到0.1 ml),加入逐步稀释的LF(从1000 pg /ml),在37℃下孵育18 - 24小时。总表观生长迟缓的样品中LF的量为该菌株的最低抑菌浓度(MIC)。结果。人LF的MIC比牛LF的MIC低4 ~ 8倍。抑制白色念珠菌所需剂量最小(分别为11.3±1.5 pg/ml和43.8±9.5 pg/ml),抑制金黄色葡萄球菌所需剂量最大(38,2±4,6),抑制牛LF -粪肠杆菌所需剂量最大(206,3±51,1)。结论。人类LF在抑制细菌感染方面要有效得多,但在进化过程中,金黄色葡萄球菌对LF的耐药性有所增加。由于牛LF的可用性较高,而且没有增加耐药性的倾向,因此建议在治疗耐药的细菌和白色念珠菌时使用高剂量的牛LF。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
Zhurnal mikrobiologii, epidemiologii, i immunobiologii
Zhurnal mikrobiologii, epidemiologii, i immunobiologii Immunology and Microbiology-Immunology and Microbiology (miscellaneous)
CiteScore
1.40
自引率
0.00%
发文量
51
审稿时长
8 weeks
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信